Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN)

紧急护理临床试验网络:紧急护理临床试验网络 (SIREN) 创新策略

基本信息

  • 批准号:
    10552366
  • 负责人:
  • 金额:
    $ 46.03万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-02-01 至 2028-01-31
  • 项目状态:
    未结题

项目摘要

The objective of this proposal is to create a new Clinical Center (Hub) organized by the Johns Hopkins Medicine Department of Emergency Medicine (JHM DEM) for the SIREN research program. The JHM Hub- and-Spoke network is comprised of nine fully committed Spoke institutions with the capacity to recruit from more than 25 unique clinical sites across five states and Washington, DC. Annual ED census of the network exceeds 1.6 million visits with strong representation of minority, socioeconomically disadvantaged and rural populations. Emergency medical services (EMS) systems associated with Hub and spokes have committed to the SIREN program through direct participation in research conducted with the JHM Hub-and-Spoke network. The JHM DEM will leverage extensive clinical research experience a robust institutional research environment to make immediate and meaningful contributions to the national SIREN program and to improve outcomes for patients with neurologic, cardiac, respiratory, hematologic, and traumatic conditions. The JHM DEM has been continuously engaged in clinical research since 1985 and is a consistent national leader in annual publications and grants, total research funding, NIH funding, and total faculty with funded research. To date, the JHM DEM has enrolled tens of thousands of patients in prospective emergency care research. The JHM Hub-and-Spoke network will achieve success for SIREN through the following Specific Aims: Aim 1: Create a Hub network administrative structure that guarantees efficient and effective recruitment for and execution of SIREN clinical trials. An innovative Hub-of-Hubs network design will allow for rapid scalability to meet individual SIREN trial needs. Tools to facilitate effective and efficient recruitment, protocol execution, data entry, and quality assurance will be disseminated across the JHM SIREN network. Aim 2. Promote diversity of inclusion in SIREN clinical trials and clinical research leadership. Improving health outcomes for underserved communities is a core clinical and research mission of JHM; promoting representation of these groups in SIREN studies will be a major focus of the JHM SIREN Hub. A second major focus will be inclusion and multi-site mentorship of women and underrepresented racial, ethnic, sexual, and gender minorities within our Hub-and-Spoke research team. Aim 3. Train future leaders in emergency care clinical trials research. Our Hub network will serve as a training environment for junior emergency care investigators (residents, fellows, junior faculty, nurses, EMS providers). Junior investigators will gain mentored experience in clinical trials research through workshops and didactics developed by the Hub, execution of SIREN trials, and participation in technical working groups including those focused on optimizing trial implementation and development of new trial proposals. These aims will be executed through a tripartite Hub organizational structure that includes (1) an Administrative Core, (2) a Governance Core, and (3) Technical Working Groups.
该提案的目的是创建由约翰·霍普金斯医学急诊医学部(JHM DEM)组织的新临床中心(HUB)为警报研究计划。 JHM枢纽和辐条网络由九个完全承诺的讲话机构组成,其能力从五个州和华盛顿特区的25多个独特的临床场所招募。该网络的年度ED人口普查超过160万次访问,对少数族裔,社会经济处于弱势群体和农村人口的代表性很高。与枢纽和辐条相关的紧急医疗服务(EMS)系统通过直接参与JHM Hub and Skoke网络进行的研究致力于警笛计划。 JHM DEM将利用广泛的临床研究体验强大的机构研究环境,为国家警笛计划做出立即有意义的贡献,并改善神经,心脏,呼吸道,血液学和创伤状况的患者的结果。自1985年以来,JHM DEM一直从事临床研究,并且是年度出版物和赠款,全面研究资金,NIH资助以及资助研究的全部教师的一致国家领导者。迄今为止,JHM DEM已将成千上万的患者纳入前瞻性急诊研究。 JHM Hub and Skoke网络将通过以下特定目的通过以下特定目的获得Siren的成功:AIM 1:创建一个集线器网络管理结构,以保证警笛临床试验的高效招募和执行。创新的枢纽网络设计将允许快速可扩展性满足单个警报试验需求。促进有效,有效招聘,协议执行,数据输入和质量保证的工具将在JHM Siren网络中传播。目标2。促进警笛临床试验和临床研究领导力中的包容性多样性。改善服务不足社区的健康结果是JHM的核心临床和研究任务。在警笛研究中促进这些群体的代表将是JHM警笛枢纽的主要重点。第二个主要重点将是我们的枢纽研究团队中的妇女以及代表性不足的种族,种族,性和性别少数群体的多站点指导。目标3。培训未来的急诊临床试验研究领导者。我们的枢纽网络将作为初级急诊研究人员(居民,研究员,初级教师,护士,EMS提供者)的培训环境。初级调查人员将通过枢纽开发的研讨会和教学术在临床试验研究中获得指导的经验,并参与技术工作组,包括专注于优化试验实施和开发新试验建议的工作组。这些目标将通过三方枢纽组织结构执行,该结构包括(1)行政核心,(2)治理核心和(3)技术工作组。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GABOR D KELEN其他文献

GABOR D KELEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GABOR D KELEN', 18)}}的其他基金

Discharge Criteria for Creation of Hospital Surge Capac*
创建医院激增容量的出院标准*
  • 批准号:
    6783245
  • 财政年份:
    2003
  • 资助金额:
    $ 46.03万
  • 项目类别:

相似国自然基金

化学小分子激活YAP诱导染色质可塑性促进心脏祖细胞重编程的表观遗传机制研究
  • 批准号:
    82304478
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
心肌源性微囊泡AEP调节巨噬细胞极化对放射性心脏损伤的保护机制研究
  • 批准号:
    82373514
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
ROS响应的化橘红融合纳米囊泡抑制心脏移植排斥的作用以及机制研究
  • 批准号:
    82302003
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于线粒体能量代谢及微循环障碍的多参数MR诊断和预测心脏移植物血管病研究
  • 批准号:
    82371903
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
应用分子影像方法探究帕金森病模型鼠心脏自主神经损伤的时间窗及心脏神经受体表达的分析
  • 批准号:
    82360352
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Reducing Ethnic-racial Disparities in Cardiac Arrest Survival Outcomes (RED-CASO)
减少心脏骤停生存结果的种族差异 (RED-CASO)
  • 批准号:
    10338932
  • 财政年份:
    2022
  • 资助金额:
    $ 46.03万
  • 项目类别:
Reducing Ethnic-racial Disparities in Cardiac Arrest Survival Outcomes (RED-CASO)
减少心脏骤停生存结果的种族差异 (RED-CASO)
  • 批准号:
    10598514
  • 财政年份:
    2022
  • 资助金额:
    $ 46.03万
  • 项目类别:
Linking State Medicaid and Congenital Heart Surgical Registry Data: Building Capacity to Assess Disparities in Longitudinal Outcomes and Value for Children with Congenital Heart Disease
将州医疗补助和先天性心脏病手术登记数据联系起来:评估先天性心脏病儿童的纵向结果差异和价值的能力建设
  • 批准号:
    10079025
  • 财政年份:
    2020
  • 资助金额:
    $ 46.03万
  • 项目类别:
Linking State Medicaid and Congenital Heart Surgical Registry Data: Building Capacity to Assess Disparities in Longitudinal Outcomes and Value for Children with Congenital Heart Disease
将州医疗补助和先天性心脏病手术登记数据联系起来:评估先天性心脏病儿童的纵向结果差异和价值的能力建设
  • 批准号:
    10543993
  • 财政年份:
    2020
  • 资助金额:
    $ 46.03万
  • 项目类别:
Linking State Medicaid and Congenital Heart Surgical Registry Data: Building Capacity to Assess Disparities in Longitudinal Outcomes and Value for Children with Congenital Heart Disease
将州医疗补助和先天性心脏病手术登记数据联系起来:评估先天性心脏病儿童的纵向结果差异和价值的能力建设
  • 批准号:
    10327311
  • 财政年份:
    2020
  • 资助金额:
    $ 46.03万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了